Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Florian M.M. Baeres
ResearcherPublications, citations & collaboration network
Florian M.M. Baeres is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 40 works, 3,575 citations, an h-index of 14 and an i10-index of 18.
40
Works
3,575
Citations
14
h-index
18
i10-index
IDs:OpenAlex
How has Florian M.M. Baeres's publication output changed over time?
ScholarIQpublication output · 2002–2026
Output grew0% over the shown period — from 1 works in 2002 to 1 in 2026.
1
1
1
1
1
1
1
3
1
200220142015201620202021202320242026
What are the most-cited papers on Florian M.M. Baeres?
ScholarIQmost cited works
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Vlado Perkovic, Katherine R. Tuttle, Peter Rossing, Kenneth W. Mahaffey, Johannes F.E. Mann, George L. Bakris, Florian M.M. Baeres, Thomas Idorn, Heidrun Bosch‐Traberg, Nanna L. Lausvig, Richard Pratley
New England Journal of Medicine. 20241,655 Citations
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
Paul M. Ridker, Matt Devalaraja, Florian M.M. Baeres, Mads D.M. Engelmann, G. Kees Hovingh, Milana Ivkovic, Larry Lo, Douglas Kling, Pablo E. Pérgola, Dominic S. Raj, Peter Libby, Michael Davidson
The Lancet. 2021692 CitationsOPEN ACCESS
The anatomy and innervation of the mammalian pineal gland
Morten Møller, Florian M.M. Baeres
S139399906. 2002278 Citations
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
Peter Rossing, Florian M.M. Baeres, George L. Bakris, Heidrun Bosch‐Traberg, Mette Gislum, Stephen Gough, Thomas Idorn, Jack Lawson, Kenneth W. Mahaffey, Johannes F.E. Mann, Henriette Mersebach, Vlado Perkovic, Katherine R. Tuttle, Richard Pratley
Nephrology Dialysis Transplantation. 2023242 CitationsOPEN ACCESS
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial
Richard E. Pratley, Katherine R. Tuttle, Peter Rossing, Søren Rasmussen, Vlado Perkovic, Olav Wendelboe Nielsen, Johannes F.E. Mann, Richard J. MacIsaac, Mikhail Kosiborod, Zdravko Kamenov, Thomas Idorn, Marco Bo Hansen, Samy Hadjadj, George L. Bakris, Florian M.M. Baeres, Kenneth W. Mahaffey
Journal of the American College of Cardiology. 2024114 CitationsOPEN ACCESS
Related on ScholarIQ
Novo Nordisk (Denmark)
Institution
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Paper
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
Paper
The anatomy and innervation of the mammalian pineal gland
Paper
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease
Paper
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial
Paper